67 results on '"Beal, M. Flint"'
Search Results
2. Simultaneous determination of tricarboxylic acid cycle metabolites by high-performance liquid chromatography with ultraviolet detection
3. HPLC determination of α-ketoglutaramate [5-amino-2,5-dioxopentanoate] in biological samples
4. Sex differences in cerebral energy metabolism in Parkinson's disease: A phosphorus magnetic resonance spectroscopic imaging study
5. Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
6. Muscling In on PGC-1α for Improved Quality of Life in ALS
7. Antioxidants in Huntington's disease
8. A neuroprotective role of the human uncoupling protein 2 (hUCP2) in a Drosophila Parkinson's Disease model
9. Biomarkers of Parkinson's disease and Dementia with Lewy bodies
10. Neuroprotective strategies involving ROS in Alzheimer disease
11. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis
12. Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death
13. Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's disease
14. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications
15. Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
16. Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease
17. Hunting-ton for New Proteases: MMPs as the New Target?
18. Promethazine protects against 3-nitropropionic acid-induced neurotoxicity
19. Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases
20. Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
21. Lenalidomide (Revlimid®) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis
22. Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins
23. Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition
24. Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model
25. Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
26. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease
27. The urokinase system of plasminogen activator plays a role in amyotrophic lateral sclerosis (ALS) pathogenesis
28. Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV
29. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease
30. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis
31. Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease
32. PGC-1α, a New Therapeutic Target in Huntington's Disease?
33. The matrix metalloproteinases inhibitor Ro 26-2853 extends survival in transgenic ALS mice
34. Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS
35. Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis
36. Mice lacking alpha-synuclein are resistant to mitochondrial toxins
37. Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
38. Somatic mitochondrial DNA mutations in single neurons and glia
39. Are mitochondria critical in the pathogenesis of Alzheimer's disease?
40. β-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients
41. Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment
42. A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities
43. Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease
44. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo
45. PL-2-1 Oxidative mechanisms, inflammation, and Alzheimer's disease pathogenesis
46. Intraneuronal Alzheimer Aβ42 Accumulates in Multivesicular Bodies and Is Associated with Synaptic Pathology
47. Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice
48. Reduced-Median-Network Analysis of Complete Mitochondrial DNA Coding-Region Sequences for the Major African, Asian, and European Haplogroups
49. In Vivo Regulation of Oxidative Phosphorylation in Cells Harboring a Stop-codon Mutation in Mitochondrial DNA-encoded Cytochrome c Oxidase Subunit I
50. Mitochondria, free radicals, and neurodegeneration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.